Dr Mathis Heydtmann
Qualifications
MD
GMC number: 4370992
Practising since: 1994
Specialties
General (internal) Medicine, Gastroenterology
Consultation times
- Monday morning, phone consultations on arrangement.
- Monday AM
- Wednesday evening telephone consultation
- Overview
Or call us on
About
Special interests
- Workup for abnormal liver results
Management of all patients with chronic liver disease: alcohol related, metabolic liver disease (including MAFLD – Metabolic Syndrome Associated Liver Disease previously also called NASH or NAFLD), viral, genetic, toxic, autoimmune (where the immune system plays up and fights against cells in the liver).
- Management of patients with advanced liver disease including patients with advanced cirrhosis, decompensation and who need assessment for liver transplant.
- Transient Elastography (using FibroScan®)
Other interests
Dr Heydtmann has an interest in communication skills, he is an appraiser for revalidation and tutor to train advanced appraisers for Scotland. He is a Mediator (Scottish Mediation) and a Negotiator (Harvard Law School Program on Negotiation) and National Panellist for consultant appointments. Dr Heydtmann is actively involved in research on different aspects of liver disease including alcohol related liver disease, fatty liver disease and the link between liver disease and deprivation.
Personal interests
Treatments and tests offered by Dr Mathis Heydtmann at Nuffield Health
- Blood test
- Colonoscopy
- Flexible sigmoidoscopy
- Liver biopsy
- Diagnostic endoscopy
- Liver function tests
Locations Dr Mathis Heydtmann works with
Related experience
Research
Dr Heydtmann obtained an MD in molecular genetics from Düsseldorf University (1996) and was awarded a The Wellcome Trust Clinical Training Fellowship to study for a PhD in liver immunology at Birmingham University, which he successfully completed in 2005. As part of his PhD he undertook a research attachment at Harvard University, Boston.
He maintains a keen interest in academic medicine by advancing medical knowledge in his field and by teaching. His research work includes a CSO-funded project on alcoholic liver disease epidemiology, health economics, genetics of liver disease, and management of chronic liver disease and he is currently involved in trials on fatty liver (NAFLD). He has published widely in hepatology in high impact factor journals.
Memberships
- British Association for the Study of the Liver (BASL)
- European Association on the Study of the Liver (EASL)
- American Association on the Study of Liver Disease (AASLD)
- Scottish Society of Gastroenterology (SSG) Council Member (Secretary 2018 – 2020)
- British Society of Gastroenterology (BSG): Member of IQILS (Improving Quality in Liver Disease) Standard development group
- Scottish Society of Physicians (SSP)
- Royal College of Physicians and Surgeons of Glasgow (RCPSG): Fellow
- Royal College of Physicians (London)
- Royal College of Physicians of Edinburgh
Other posts held
- Consultant Hepatologist, Dumfries & Galloway Royal Infirmary
Insurers Dr Mathis Heydtmann works with
Dr Mathis Heydtmann works with the following private medical insurance providers:
- Aetna
- Allianz
- Aviva Health
- AXA Health
- AXA - Global Healthcare
- Bupa
- Bupa Global
- Bupa On Demand
- Benenden Health
- Cigna
- Cigna International
- CS Healthcare
- Exeter Family Friendly
- Healix
- Health-on-Line
- Police Mutual
- Simplyhealth
- Standard Life
- Universal Provident
- Vitality Health (Pru Health)
- Westfield Health WPA
- WPA
Declaration
Dr Mathis Heydtmann does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.
Dr Mathis Heydtmann does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.
Dr Mathis Heydtmann does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.